The Role of PARP Inhibitors in Prostate Cancer

August 9, 2016
Christopher E. Barbieri, MD, PhD

Christopher E. Barbieri, MD, PhD, surgeon, researcher in prostate cancer, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and New-York Presbyterian, discusses the role of PARP inhibitors in castration-resistant prostate cancer.